GlobeNewswire

Apellis Pharmaceuticals' Chief Commercial Officer Adam Townsend

Apellis Chief Commercial Officer Adam Townsend

Apellis Pharmaceuticals, Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, announced today the appointment of Adam Townsend as Chief Commercial Officer.
Apellis Pharmaceuticals, Inc.
Format

JPEG

Source

Apellis Pharmaceuticals, Inc.

Downloads